Trial Profile
Placebo-Controlled, Crossover, Double-Blind Study of KW-6002 (Istradefylline) in the Treatment of Parkinson's Disease [Monotherapy].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 30 Oct 2010 New trial record